Clinical staging and operative reporting for multi-institutional trials in head and neck squamous cell carcinoma

Head and Neck

Volumn 19, Issue 8, 1997, Pages 650-658

  Weymuller Jr , Ernest A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cancer staging; Multi institutional trials; Stratification; Surgery

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMORBIDITY; COMPUTER PROGRAM; DATA BASE; HEAD AND NECK CARCINOMA; HUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURGICAL PATIENT;

CARCINOMA, SQUAMOUS CELL; DATA COLLECTION; HEAD AND NECK NEOPLASMS; HUMANS; MULTICENTER STUDIES; NEOPLASM STAGING;

EID: 1842411371     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(199712)19:8<650::AID-HED2>3.0.CO;2-4     Document Type: Article

References (13)

1. Bone RC. Why sepsis trials fail. JAMA 1996;276:565-566.
2. Weymuller EA Jr, Ahmad K, Casiano RR, et al. Surgical reporting instrument designed to improve outcome data in head and neck cancer trials. Ann Otol Rhinol Laryngol 1994;103:499-509.
3. Jacobs C, Makuch R. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the head and neck contracts program. J Clin Oncol 1990;8:838-847.
4. Sylvester RJ, Pinedo HM, DePauw M, et al. Quality of institutional participation in multicenter clinical trials. N Engl J Med 1981;305:852-855.
5. Gasparini G, Pozza F, Harris AL. Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J Natl Cancer Inst 1993;85:1206-1219.
6. Capron AM. Human experimentation. In: Veatch RM, ed. Medical ethics. Boston: Jones and Bartlett Publishers, 1989.
7. Kaplan MH, Feinstein AR. The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 1974;27:387-404.
8. Charlson ME,Pompei P, Alex HL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40: 373-383.
9. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948;1:634-656.
10. Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 health survey. Manual and interpretation guide. Boston: The Health Institute, 1993.
11. Goldman L, Caldera DL, Southwick FS, et al. Cardiac risk factors and complications in non-cardiac surgery. Medicine 1978;57:357-370.
12. Vacanti CJ, VanHouten RJ, Hill RC. A statistical analysis of the relationship of physical status to postoperative mortality in 68,388 cases. Anesth Analg 1970;49:564-566.
13. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA 1984;252:1905-1907.